Principal component analysis, a useful tool to study cyclin-dependent kinase-inhibitor's effect on cerebral ischaemia.

CDK inhibitor NeuroVascular Unit ischaemic stroke oedema

Journal

Brain communications
ISSN: 2632-1297
Titre abrégé: Brain Commun
Pays: England
ID NLM: 101755125

Informations de publication

Date de publication:
2020
Historique:
received: 20 04 2020
revised: 30 06 2020
accepted: 06 07 2020
entrez: 23 10 2020
pubmed: 24 10 2020
medline: 24 10 2020
Statut: epublish

Résumé

Stroke is a leading cause of acute death related in part to brain oedema, blood-brain barrier disruption and glial inflammation. A cyclin-dependant kinase inhibitor, (S)-roscovitine, was administered 90 min after onset on a model of rat focal cerebral ischaemia. Brain swelling and Evans Blue tissue extravasation were quantified after Evans Blue injection. Combined tissue Evans Blue fluorescence and immunofluorescence of endothelial cells (RECA1), microglia (isolectin-IB4) and astrocytes (glial fibrillary acidic protein) were analysed. Using a Student's

Identifiants

pubmed: 33094284
doi: 10.1093/braincomms/fcaa136
pii: fcaa136
pmc: PMC7566348
doi:

Types de publication

Journal Article

Langues

eng

Pagination

fcaa136

Informations de copyright

© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.

Références

Neuroscience. 2019 May 1;405:55-67
pubmed: 31007172
Semin Neurol. 2016 Dec;36(6):502-507
pubmed: 27907954
PLoS One. 2010 Aug 12;5(8):e12117
pubmed: 20711428
Arch Neurol. 1996 Apr;53(4):309-15
pubmed: 8929152
Clin Pharmacol Ther. 2012 Feb;91(2):327-32
pubmed: 22218073
J Cereb Blood Flow Metab. 2008 Nov;28(11):1845-59
pubmed: 18612315
Lancet Neurol. 2019 May;18(5):439-458
pubmed: 30871944
Neurosci Lett. 2015 Jan 1;584:368-72
pubmed: 25449874
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10254-9
pubmed: 10944192
J Cereb Blood Flow Metab. 2015 Dec;35(12):1937-49
pubmed: 26104286
Pharmacol Rev. 2005 Jun;57(2):173-85
pubmed: 15914466
FEBS Lett. 2005 Aug 29;579(21):4591-9
pubmed: 16098510
Arch Neurol. 1959 Aug;1:161-77
pubmed: 14445627
J Cereb Blood Flow Metab. 2018 Jun;38(6):1070-1084
pubmed: 28569655
Cells. 2019 Jul 19;8(7):
pubmed: 31331032
FASEB J. 2019 Mar;33(3):4376-4387
pubmed: 30694693
Exp Neurol. 2019 Aug;318:135-144
pubmed: 31028828
Brain Behav Immun. 2019 Feb;76:126-138
pubmed: 30453020
Int J Mol Sci. 2015 Apr 30;16(5):9949-75
pubmed: 25941935
J Biol Chem. 2005 Sep 2;280(35):31208-19
pubmed: 15975926
J Neurosci. 2014 Jun 11;34(24):8259-67
pubmed: 24920629
Gene Ther. 2011 May;18(5):462-8
pubmed: 21160532
Intensive Care Med. 1998 Jun;24(6):620-3
pubmed: 9681786
Neurosurg Rev. 1998;21(4):290-4
pubmed: 10068193
Neurosci Res. 2017 Jun;119:24-37
pubmed: 28153522
Front Cell Neurosci. 2014 Nov 03;8:362
pubmed: 25404894
J Neurochem. 2019 Oct;151(2):166-184
pubmed: 31314915
Br J Pharmacol. 2011 Jul;163(5):1086-98
pubmed: 21391976
Glia. 2009 Jun;57(8):908-20
pubmed: 19115378
J Neurosci. 2012 May 2;32(18):6391-410
pubmed: 22553043
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
Eur J Biochem. 1997 Jan 15;243(1-2):527-36
pubmed: 9030781
Mol Neurobiol. 2018 Nov;55(11):8563-8585
pubmed: 29564811
Neurology. 1995 Jul;45(7):1286-90
pubmed: 7617183
Front Cell Neurosci. 2017 Aug 08;11:235
pubmed: 28848398
PLoS One. 2013;8(3):e59712
pubmed: 23544088
Brain Pathol. 2007 Jan;17(1):11-23
pubmed: 17493033
Nat Biotechnol. 2018 Oct;36(9):865-874
pubmed: 30125269
J Physiol. 1890 Jan;11(1-2):85-158.17
pubmed: 16991945
Trends Immunol. 2016 Sep;37(9):608-620
pubmed: 27443914
Sci Rep. 2019 Sep 10;9(1):13032
pubmed: 31506563
Neurochem Res. 2015 Feb;40(2):317-28
pubmed: 24996934
Front Neurosci. 2019 Aug 07;13:781
pubmed: 31440125
J Neurosci Methods. 1983 May;8(1):41-9
pubmed: 6876872
Curr Opin Cell Biol. 2015 Feb;32:121-30
pubmed: 25726916
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12742-7
pubmed: 11675505
J Biol Chem. 2005 Oct 7;280(40):33811-8
pubmed: 16091365
Nat Med. 2000 Feb;6(2):159-63
pubmed: 10655103
Lancet Neurol. 2009 Apr;8(4):326-33
pubmed: 19269254
Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8333-8
pubmed: 15923260
Mol Cell Biol. 2012 Jan;32(2):242-50
pubmed: 22083955
Cell Death Dis. 2019 Jun 20;10(7):487
pubmed: 31221990
J Neurosci. 1999 Jul 15;19(14):6017-26
pubmed: 10407039
Prog Neurobiol. 2016 Sep;144:103-20
pubmed: 26455456
Mol Brain. 2016 Jun 07;9(1):63
pubmed: 27267759
J Cereb Blood Flow Metab. 2007 Dec;27(12):1941-53
pubmed: 17440490
Lancet Neurol. 2007 Mar;6(3):215-22
pubmed: 17303527
Neurosci Lett. 2003 Dec 15;353(1):29-32
pubmed: 14642430
Lab Invest. 1992 Apr;66(4):459-66
pubmed: 1583886
J Biol Chem. 1951 Nov;193(1):265-75
pubmed: 14907713
J Neurochem. 2013 Aug;126(4):428-36
pubmed: 23413818

Auteurs

Lucas Le Roy (L)

Univ Brest, Inserm, EFS, UMR 1078, Genetics, functional genomics and biotechnology (GGB), F-29200, Brest, France.

Ahmed Amara (A)

Univ Brest, Inserm, EFS, UMR 1078, Genetics, functional genomics and biotechnology (GGB), F-29200, Brest, France.

Cloé Le Roux (C)

Univ Brest, Inserm, EFS, UMR 1078, Genetics, functional genomics and biotechnology (GGB), F-29200, Brest, France.

Ozvan Bocher (O)

Univ Brest, Inserm, EFS, UMR 1078, Genetics, functional genomics and biotechnology (GGB), F-29200, Brest, France.

Anne Létondor (A)

Univ Brest, Inserm, EFS, UMR 1078, Genetics, functional genomics and biotechnology (GGB), F-29200, Brest, France.

Nathalie Benz (N)

Univ Brest, Inserm, EFS, UMR 1078, Genetics, functional genomics and biotechnology (GGB), F-29200, Brest, France.

Serge Timsit (S)

Univ Brest, Inserm, EFS, UMR 1078, Genetics, functional genomics and biotechnology (GGB), F-29200, Brest, France.
Neurology and Stroke Unit Department, CHRU de Brest, Université de Bretagne Occidentale, Inserm 1078, France.

Classifications MeSH